Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1998-7-9
|
| pubmed:abstractText |
D-Limonene is a natural monoterpene with pronounced chemotherapeutic activity and minimal toxicity in preclinical studies. A phase I clinical trial to assess toxicity, the maximum tolerated dose (MTD) and pharmacokinetics in patients with advanced cancer was followed by a limited phase II evaluation in breast cancer.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0344-5704
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
42
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
111-7
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:9654110-Adult,
pubmed-meshheading:9654110-Aged,
pubmed-meshheading:9654110-Aged, 80 and over,
pubmed-meshheading:9654110-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:9654110-Cyclohexenes,
pubmed-meshheading:9654110-Female,
pubmed-meshheading:9654110-Humans,
pubmed-meshheading:9654110-Male,
pubmed-meshheading:9654110-Middle Aged,
pubmed-meshheading:9654110-Neoplasms,
pubmed-meshheading:9654110-Terpenes,
pubmed-meshheading:9654110-Treatment Outcome
|
| pubmed:year |
1998
|
| pubmed:articleTitle |
Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee.
|
| pubmed:affiliation |
Department of Medical Oncology, Charing Cross Hospital, London, UK. d.vigushin@cxwms.ac.uk
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II,
Clinical Trial, Phase I
|